Merus N.V.
MRUSDelisted Dec 30, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001651311
Merus N.V. was delisted on Dec 30, 2025; its insiders filed their last Form 4 on Dec 30, 2025; 268 institutions reported holding it in 13F filings for Q3 2025, worth $6.70B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q4 2022
Institutional positions in Merus N.V. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 91
- −8 vs. Q3 2022
- Shares held
- 36.4M
- +2.13M (+6.2%) vs. Q3 2022
- Total value
- $563.8M
- −$123.6M (−18.0%) vs. Q3 2022
- New holders
- 16
- 30 more added
- Sold out
- 24
- 30 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MRUS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 10 | $5.73M |
| Q3 2025 | 268 | $6.70B |
| Q2 2025 | 201 | $3.93B |
| Q1 2025 | 185 | $2.98B |
| Q4 2024 | 192 | $2.96B |
| Q3 2024 | 189 | $3.45B |
| Q2 2024 | 179 | $3.94B |
| Q1 2024 | 156 | $2.31B |
| Q4 2023 | 131 | $1.41B |
| Q3 2023 | 113 | $1.12B |
| Q2 2023 | 114 | $1.09B |
| Q1 2023 | 104 | $672.0M |
| Q4 2022 | 91 | $563.8M |
| Q3 2022 | 100 | $687.4M |
| Q2 2022 | 93 | $793.4M |
| Q1 2022 | 95 | $878.1M |
| Q4 2021 | 103 | $1.05B |
| Q3 2021 | 64 | $487.8M |
| Q2 2021 | 68 | $564.3M |
| Q1 2021 | 59 | $558.3M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Merus N.V.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Acuta Capital Partners, LLC | 0 | $0 | 0.00% | −59,000−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −51,773−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −42,225−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −36,994−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −33,063−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −31,000−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −29,001−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −28,645−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −20,993−100.0% | Sold out |
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −17,963−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −12,518−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −10,898−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −10,313−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −1,321−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −653−100.0% | Sold out |
| FourThought Financial, LLC | – | – | – | – | Not filed |